110 related articles for article (PubMed ID: 16547384)
1. [Antithrombin and protein C activity in the blood of premature newborns with intrauterine growth retardation].
Korbal P; Szymański W; Janiszewska T; Cwiklińska-Jurkowska M; Adamczak R; Sadowska-Krawczenko I
Med Wieku Rozwoj; 2005; 9(3 Pt 1):370-82. PubMed ID: 16547384
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
[TBL] [Abstract][Full Text] [Related]
3. Increased morbidity in severe early intrauterine growth restriction.
Aucott SW; Donohue PK; Northington FJ
J Perinatol; 2004 Jul; 24(7):435-40. PubMed ID: 15116139
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine growth restriction increases morbidity and mortality among premature neonates.
Garite TJ; Clark R; Thorp JA
Am J Obstet Gynecol; 2004 Aug; 191(2):481-7. PubMed ID: 15343225
[TBL] [Abstract][Full Text] [Related]
5. [Intrauterine growth retardation--perinatal mortality and postnatal morbidity in a perinatal center].
Meyberg R; Boos R; Babajan A; Ertan AK; Schmidt W
Z Geburtshilfe Neonatol; 2000; 204(6):218-23. PubMed ID: 11199150
[TBL] [Abstract][Full Text] [Related]
6. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
Topper MJ; Prasse KW
Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
[TBL] [Abstract][Full Text] [Related]
7. The red cell distribution width (RDW): value and role in preterm, IUGR (intrauterine growth restricted), full-term infants.
Garofoli F; Ciardelli L; Mazzucchelli I; Borghesi A; Angelini M; Bollani L; Genini E; Manzoni P; Paolillo P; Tinelli C; Merlini G; Stronati M
Hematology; 2014 Sep; 19(6):365-9. PubMed ID: 24225072
[TBL] [Abstract][Full Text] [Related]
8. Refeeding syndrome in very-low-birth-weight intrauterine growth-restricted neonates.
Ross JR; Finch C; Ebeling M; Taylor SN
J Perinatol; 2013 Sep; 33(9):717-20. PubMed ID: 23538644
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life.
Cianfarani S; Germani D; Rossi P; Rossi L; Germani A; Ossicini C; Zuppa A; Argirò G; Holly JM; Branca F
Pediatr Res; 1998 Sep; 44(3):374-80. PubMed ID: 9727716
[TBL] [Abstract][Full Text] [Related]
10. [Nutritional and Hormonal Status of Premature Infants Born with Intrauterine Growth Restriction at the Term Corrected Age].
Belyaeva IA; Namazova-Baranova LS; Bombardirova EP; Okuneva MV
Vestn Ross Akad Med Nauk; 2016; 71(6):436-45. PubMed ID: 29298007
[TBL] [Abstract][Full Text] [Related]
11. [Complications due to malnutrition and intrauterine growth restriction in preterm newborns].
Arteaga-Mancera MP; Rendón-Macías ME; Iglesias-Leboreiro J; Bernárdez-Zapata I; Ortiz-Maldonado F
Rev Med Inst Mex Seguro Soc; 2014; 52(2):204-11. PubMed ID: 24758861
[TBL] [Abstract][Full Text] [Related]
12. Neural injury markers to predict neonatal complications in intrauterine growth restriction.
Velipaşaoğlu M; Yurdakök M; Özyüncü Ö; Portakal O; Deren Ö
J Obstet Gynaecol; 2015; 35(6):555-60. PubMed ID: 25392968
[TBL] [Abstract][Full Text] [Related]
13. The IUGR newborn.
Rosenberg A
Semin Perinatol; 2008 Jun; 32(3):219-24. PubMed ID: 18482625
[TBL] [Abstract][Full Text] [Related]
14. Dysfunctional antithrombin III in sick premature infants.
Andrew M; Massicotte-Nolan P; Mitchell L; Cassidy K
Pediatr Res; 1985 Feb; 19(2):237-9. PubMed ID: 3982886
[TBL] [Abstract][Full Text] [Related]
15. Levels and patterns of intrauterine growth retardation in developing countries.
de Onis M; Blössner M; Villar J
Eur J Clin Nutr; 1998 Jan; 52 Suppl 1():S5-15. PubMed ID: 9511014
[TBL] [Abstract][Full Text] [Related]
16. Short-term and long-term sequelae in intrauterine growth retardation (IUGR).
Longo S; Bollani L; Decembrino L; Di Comite A; Angelini M; Stronati M
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):222-5. PubMed ID: 23030765
[TBL] [Abstract][Full Text] [Related]
17. Prematurity and intrauterine growth retardation--double jeopardy?
Regev RH; Reichman B
Clin Perinatol; 2004 Sep; 31(3):453-73. PubMed ID: 15325532
[TBL] [Abstract][Full Text] [Related]
18. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
19. Differential vulnerability of gray matter and white matter to intrauterine growth restriction in preterm infants at 12 months corrected age.
Padilla N; Junqué C; Figueras F; Sanz-Cortes M; Bargalló N; Arranz A; Donaire A; Figueras J; Gratacos E
Brain Res; 2014 Jan; 1545():1-11. PubMed ID: 24361462
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome.
Dessì A; Atzori L; Noto A; Visser GH; Gazzolo D; Zanardo V; Barberini L; Puddu M; Ottonello G; Atzei A; De Magistris A; Lussu M; Murgia F; Fanos V
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():35-9. PubMed ID: 21767100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
